[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.147.238.168. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
September 2, 1992

Continuing Medical EducationUnabated Debate

Author Affiliations

From the Division of Continuing Medical Education, American Medical Association, Chicago, III.

JAMA. 1992;268(9):1118-1120. doi:10.1001/jama.1992.03490090060015
Abstract

EVENTS in 1991 and 1992 reflected continuing widespread debate about the form continuing medical education (CME) should take, who should provide it, the role commercial companies should play in paying for it, and how successful completion of specific CME activities should be documented. The American Medical Association (AMA) House of Delegates reviewed the Physician's Recognition Award (PRA) certification requirements and referred questions concerning the requirements to the AMA Board of Trustees for decision. A number of CME organizations joined to develop voluntary standards for industry funding of CME and rules for disclosure of conflict of interest by CME faculty.

The Food and Drug Administration (FDA) took an interest in industry relationships to CME—the first time the federal government has taken a major interest in CME management. The AMA and the American Hospital Association developed a form that CME providers can use to document physician participation in activities directed toward expanding

×